Pernix Therapeutics (Nasdaq: PTX) reported a loss for the first quarter of 42 cents per share compared with a loss of 62 cents per share in the year ago period as revenue fell. Shares of the specialty pharmaceutical tumbled 44 cents to $0.61.
Pernix Therapeutics reports loss
May 05, 2016 at 12:54 PM EDT
